0.5248
price down icon4.58%   -0.0252
after-market アフターアワーズ: .52 -0.0048 -0.91%
loading
前日終値:
$0.55
開ける:
$0.543
24時間の取引高:
75,097
Relative Volume:
0.11
時価総額:
$32.42M
収益:
-
当期純損益:
$-68.80M
株価収益率:
-0.4485
EPS:
-1.17
ネットキャッシュフロー:
$-59.06M
1週間 パフォーマンス:
-6.29%
1か月 パフォーマンス:
-14.94%
6か月 パフォーマンス:
-29.72%
1年 パフォーマンス:
-57.68%
1日の値動き範囲:
Value
$0.5202
$0.565
1週間の範囲:
Value
$0.5202
$0.5917
52週間の値動き範囲:
Value
$0.451
$1.79

Passage Bio Inc Stock (PASG) Company Profile

Name
名前
Passage Bio Inc
Name
セクター
Healthcare (1169)
Name
電話
(267) 866-0312
Name
住所
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Name
職員
85
Name
Twitter
@passage_bio
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
PASG's Discussions on Twitter

PASG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PASG
Passage Bio Inc
0.5248 32.42M 0 -68.80M -59.06M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-29 再開されました Wedbush Outperform
2024-09-03 開始されました Rodman & Renshaw Buy
2022-03-08 ダウングレード JP Morgan Overweight → Neutral
2022-01-19 ダウングレード Goldman Buy → Neutral
2021-07-01 開始されました Raymond James Outperform
2021-06-15 開始されました BTIG Research Buy
2021-03-04 アップグレード Goldman Neutral → Buy
2021-02-04 開始されました Guggenheim Buy
2021-01-25 開始されました Wedbush Outperform
2021-01-04 アップグレード JP Morgan Neutral → Overweight
2020-12-11 開始されました Citigroup Neutral
2020-08-14 ダウングレード JP Morgan Overweight → Neutral
2020-06-25 ダウングレード Goldman Buy → Neutral
2020-03-25 開始されました Chardan Capital Markets Buy
2020-03-24 開始されました Cowen Outperform
2020-03-24 開始されました Goldman Buy
2020-03-24 開始されました JP Morgan Overweight
すべてを表示

Passage Bio Inc (PASG) 最新ニュース

pulisher
Feb 21, 2025

Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace

Feb 21, 2025
pulisher
Feb 21, 2025

Passage Bio Inc to Host Earnings Call - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Passage Bio (NASDAQ:PASG) versus SpringWorks Therapeutics (NASDAQ:SWTX) Head to Head Review - Defense World

Feb 21, 2025
pulisher
Feb 16, 2025

Passage Bio will again trim workforce in latest cost-cutting move - The Business Journals

Feb 16, 2025
pulisher
Feb 13, 2025

Passage Bio CFO sells shares worth $1,685 - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff - Fierce Biotech

Feb 13, 2025
pulisher
Feb 12, 2025

Passage Bio CFO sells shares worth $1,685 By Investing.com - Investing.com UK

Feb 12, 2025
pulisher
Feb 12, 2025

2024 Q4 Job Market Report: Biopharma Job Postings Slowed as Layoffs Continued - BioSpace

Feb 12, 2025
pulisher
Feb 03, 2025

Passage Bio shares transition to Nasdaq Capital Market - MSN

Feb 03, 2025
pulisher
Feb 01, 2025

Passage Bio shares transition to Nasdaq Capital Market By Investing.com - Investing.com South Africa

Feb 01, 2025
pulisher
Jan 25, 2025

TELA Bio Grants Inducement Stock Units to New Employees - MyChesCo

Jan 25, 2025
pulisher
Jan 20, 2025

Passage Bio Out-Licenses Rare Disease Programs to GEMMA Biotherapeutics - MSN

Jan 20, 2025
pulisher
Jan 17, 2025

Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap - MyChesCo

Jan 17, 2025
pulisher
Jan 14, 2025

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc - GuruFocus.com

Jan 14, 2025
pulisher
Jan 14, 2025

Orbimed advisors reduces stake in Passage Bio for $142,223 By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Passage Bio Reports Promising Data in Trial for Frontotemporal Dementia Treatment - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Orbimed advisors reduces stake in Passage Bio for $142,223 - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel to Monitor Treatment Journey for Patients with Traumatic Brain Injury and Alzheimer's - BioSpace

Jan 14, 2025
pulisher
Jan 13, 2025

Passage Bio Cutting 55% of Staff to Help Extend Cash Runway - BioSpace

Jan 13, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Has $351,000 Position in Nutriband Inc. (NASDAQ:NTRB) - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

Passage Bio (NASDAQ:PASG) Announces Restructuring Plan and Financial Update - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

Head-To-Head Comparison: Passage Bio (NASDAQ:PASG) vs. JATT Acquisition (NYSE:JATT) - Defense World

Jan 13, 2025

Passage Bio Inc (PASG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):